These observations give reasons for the high prevalence of GRASLND expression in immunologically “cold tumors.” The observed immunological functions of GRASLND in melanoma are supported by a bioinformatical prediction study in gastric cancer, that identified GRASLND as an immune-related lncRNA with a negative prognostic factor for ICI response (Ding et al., 2021). Here, GRASLND is linked to gastric cancer.